Grad Cosmin, Grad Simona, Fărcaş Radu A, Popa Stefan, Dumitraşcu Dan L
Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
2 Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Med Pharm Rep. 2023 Jul;96(3):229-234. doi: 10.15386/mpr-2538. Epub 2023 Jul 27.
Currently being the seventh most prevalent form of cancer worldwide, and the fifth most common cause of cancer-related death, based on GLOBOCAN 2020 data, gastric cancer is still an important public health problem, despite its dropping incidence. Regions around the world are still at high-risk, mostly in populations with a high prevalence of Helicobacter pylori infection or a carcinogenic favorable diet. Gastric cardia cancer incidence is on the rise in some areas. Great steps were made in the last decades in understanding the pathogenesis of gastric cancer and its risk factors. Host genetic polymorphisms play a quintessential role in disease outcome. Helicobacter pylori eradication and endoscopic surveillance are the most effective options to further decrease gastric cancer incidence. Surgery is required for a curative treatment in most cases. This review summarizes the latest worldwide epidemiological data of gastric cancer and aims to provide an accessible and credible source of evidence for physicians who assess risk factors for gastric cancer.
根据2020年全球癌症负担数据(GLOBOCAN),胃癌目前是全球第七大常见癌症,也是癌症相关死亡的第五大常见原因。尽管其发病率呈下降趋势,但胃癌仍然是一个重要的公共卫生问题。世界各地的一些地区仍然处于高风险状态,主要是在幽门螺杆菌感染率高或饮食致癌因素有利的人群中。在某些地区,贲门癌的发病率正在上升。在过去几十年里,在了解胃癌的发病机制及其风险因素方面取得了巨大进展。宿主基因多态性在疾病转归中起着至关重要的作用。根除幽门螺杆菌和内镜监测是进一步降低胃癌发病率的最有效选择。在大多数情况下,治愈性治疗需要手术。本综述总结了全球最新的胃癌流行病学数据,旨在为评估胃癌风险因素的医生提供一个易于获取且可靠的证据来源。